|
2
Votes
vote
Altered state physiology drug development platform to treat an array of human conditionsDavid H. Fater, CEO of Vicor Technologies, Inc., today announced that on July 23, 2009, the Australian Patent Office issued it a Deed of Letters Patent for its altered state physiology drug development platform. Vicor Technologies is a biotechnology company focused on the commercialization of innova ... |
|
2
Votes
vote
Vicor Technologies Issued Australian Patent for Its Altered State Physiology Drug Development PlatformBOCA RATON, FL--(Marketwire - September 29, 2009) - David H. Fater, CEO of Vicor Technologies, Inc. (OTCBB: VCRT), today announced that on July 23, 2009, the Australian Patent Office issued it a Deed of Letters Patent for its altered state physiology drug development platform. Vicor Technologies i ... |
Get Keegy on your site
Put Keegy everywhere
Add buttons to know your online users , ranking position o your visitors vote your stories.

